Tuesday, April 29, 2014

Mets Day 747: What causes bladder cancer

Scientists have known for some time of an association between smoking and bladder cancer. But there has been little understanding of how bladder cancer actually gets started, especially because it can mutate so quickly. A just-published study out of Stanford claims to have definitively answered the question, however. The study, titled "Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma", by Shin, et al., was published online in Nature Cell Biology on April 20, 2014. An abstract is available here. I could not find the full version of the article on a free website; fortunately, my daughter who is graduating from medical school next month was able to get the complete article and send it to me. 

In short, the study says that all bladder cancers start from a certain type of stem cell in basal urothelium -- the lining of the bladder. The specific characteristic of the cancer-triggering stem cell is that it expresses a certain type of protein with the real, but incredibly stupid, name of Sonic hedgehog. The researcher chose the name after Sonic the Hedgehog, a character in the Sega video game.  The abbreviation for the Sonic hedgehog protein is Shh. 

The Stanford article details how the researchers isolated the Shh protein and showed that the mutations from Shh-expressing stem cells were solely responsible for all bladder cancers in mice, which closely mimic human bladders. Once those Shh-expressing stem cells start cloning themselves, they rapidly displace all other types of cells in the lining of the bladder. Amazingly, once the cells start forming tumours, they lose their Shh-expressing characteristics. This is why mature bladder cancer tumours do not reflect their origin in Shh-expressing stem cells.

Figure 8 of the study contains a graphic that details the progression from normal cells lining the bladder to bladder cancer tumours. (Figure 8 can be viewed in the abstract by clicking through the figures under the "at a glance" tab.) The concluding paragraph of the article says:
The events of carcinoma initiation and progression are summarized in Fig. 8, and begin with accumulation of mutations in Shh-expressing urothelial basal stem cells, the cancer cell of origin. These mutations allow the progeny of a single cell to sweep through and colonize an extensive portion of the urothelium and form a CIS precursor lesion. Within this lesion, Shh-positive basal cells accumulate further mutations, leading to further clonal expansion and ultimately to trans-formation and invasion of the stromal and muscle layers of the bladder. The latter stages of this process are consistently accompanied by loss or attenuation of Shh expression, and further studies will be required to establish the significance of this loss. One of the key features of our findings is that progression to invasion occurs in the context of a precursor lesion with pre-neoplastic changes that aggressively spreads through most if not all of the urothelium. Resection of invasive carcinomas, even if complete, thus may leave in place urothelial cells that already have taken several early steps along the path to invasive tumour formation, thus potentially accounting for the frequent recurrence and high morbidity of invasive human bladder cancer.
I've never smoked, so there is no obvious explanation of what caused my bladder cancer. But now I know it's because of a mutation in my bladder stem cell gene called Sonic hedgehog.

The article does not suggest how patients with existing metastatic bladder cancer can be cured. Mature bladder cancer tumours, both within the bladder, and metastatic, have a number of mutations and characteristics that make it a very hard cancer to kill. But by identifying the definitive pathway by which bladder cancer starts, this study is an important step forward for diagnosing and treating early bladder cancers, and eventually learning how to prevent the cancer from forming at all.

Monday, April 28, 2014

Mets Day 746: Days of future past

As I find common in my life, these past few weeks have had no momentous happenings; rather, the steady pace of life marches on day by day.  I give thanks each morning for another sunrise, and thanks at the end of the day for another day with my family.  During the weekdays, I get to spend time with my granddaughter, aware that she, as well as my daughter and son-in-law, soon will be moving 2000 miles away.  We've already booked out flights to visit her (and a few others) in early July. 

This evening my younger daughter returned home from her first year of college, and immediately went to bed.  I suspect she will stay there for several days as she recharges from finals. It will be nice to have her home for the summer. Meanwhile, my youngest son is learning how to drive, and I'm bracing for the financial hit that comes when a 16 year old male is added to the car insurance.

April 11 marked the date in 2012 that a CT scan revealed that my BC had metastasized into my lymph nodes, and the day that I started my "mets day" count in the titles of each blog. I've thus entered my third year of mets BC. This puts me past the median of historical durations for overall survival.  Every day is another little victory in my personal battle. I keep count in each blog post as a way of reminding myself, and perhaps others, that there is ongoing hope.

Each Monday, I get an email from BCAN with links to questions from people about bladder cancer. Sometimes its the patient, sometimes its a relative of a patient. I look through the questions for those that I might be able to add something. About 70% of people diagnosed with bladder cancer have a relatively minor type that can be treated by TURBT procedures and BCG washes of the bladder. While many of those patients are freaked out at the idea of a cancer diagnosis and are coming to BCAN for information and reassurance, they are the lucky ones. I ignore their questions, and instead plunge into those dealing with chemotherapy issues, or recovery from radical cystectomy (bladder removal) surgery, or dealing with neobladder troubles, or confronting a diagnosis of metastatic cancer.  I usually spend several hours each Monday answering questions from my perspective, adding links to my blog, and inviting one-on-one follow-ups. I know how difficult it was when I was going through all of those challenges, and found comfort in the collective wisdom from others in the BCAN community. I try to add a little light to the community, in hopes that it will aid and comfort others.  I usually get several follow-up emails each week from my postings.

Last week, one of the people who reached out to me was a patent attorney from Ohio with whom I had done some work several years ago.  He said he had read through most of my blog before he figured out who I was, and reached out to me. It's a small world.

As an aside, yesterday one of my friends emailed me and said that I was named in Sunday's Washington Post Magazine as a "Super Lawyer" for 2014 in Intellectual Property Law. I was amused to learn that, since I haven't had a consistent legal practice for a while. I was aware that I had been so listed last year, but didn't think it would be continued. Maybe I was so named because slowing my practice has raised the average for other IP lawyers.

This weekend is the BCAN walk -- if you're still reading, it's not too late to make a donation by going to this link. For those of you who have made donations, thank you.  

Thursday, April 3, 2014

Mets Day 721 - Join Team Kbros

Please join with me in this year's Bladder Cancer Advocacy Network (BCAN) Walk for Bladder Cancer, on Saturday, May 3, on the National Mall in Washington DC.  I've set up a Team Kbros page to collect donations and register those who want to join the walk. I've set a goal to raise $2500 for BCAN in the next 30 days. Please click on this link to join my team, or just to make a donation. You can donate anonymously, if you want.

While I do not expect researchers to find a cure for bladder cancer soon enough to help my metastatic cancer, every step forward helps build a greater foundation of understanding.  Although bladder cancer is the fifth most common cancer in the US (and fourth most common in men), it is near the bottom in the level of federal cancer funding.

Thank you for support!

(By the way, here's what I put on my team page):

I was diagnosed with bladder cancer on November 22, 2011. This walk will mark two years since my cancer metastasized. Currently there is no cure for metastatic bladder cancer.  I'm walking to support the research for a cure, and to celebrate the hope and joy of life.

This year, 73,000 people will be diagnosed with bladder cancer.  15,000 people will not survive their bladder cancer journey this year. 

Bladder cancer is the 5th most commonly diagnosed cancer in the US.  It affects both men and women of all ages and races, although men are 4 times more likely to be diagnosed. Women, however, have higher mortality rates due to delayed diagnosis.

Through innovative programs such as the Bladder Cancer Think Tank - the only scientific symposium dedicated solely to bladder cancer, BCAN is helping to change these odds.

Walk with me or donate and help us beat these odds!

$25 gives 50 people educational materials to navigate their bladder cancer journey
$50 will help produce a webinar about bladder cancer research
$100 helps a Young Investigator attend BCAN's Think Tank

Thank you for stepping up and helping me change the lives of those impacted by bladder cancer.

I was diagnosed with bladder cancer on November 22, 2011. This walk will mark two years since my cancer metastasized. Currently there is no cure for metastatic bladder cancer. I'm walking to support the research for a cure, and to celebrate the hope and joy of life.

This year, 73,000 people will be diagnosed with bladder cancer. 15,000 people will not survive their bladder cancer journey this year.

Bladder cancer is the 6th most commonly diagnosed cancer in the US. It affects both men and women of all ages and races, although men are 4 times more likely to be diagnosed. Women, however, have higher mortality rates due to delayed diagnosis.

Through innovative programs such as the Bladder Cancer Think Tank - the only scientific symposium dedicated solely to bladder cancer, BCAN is helping to change these odds.

Walk with me or donate and help us beat these odds!

$25 gives 50 people educational materials to navigate their bladder cancer journey
$50 will help produce a webinar about bladder cancer research
$100 helps a Young Investigator attend BCAN's Think Tank

Thank you for stepping up and helping me change the lives of those impacted by bladder cancer. - See more at: http://dcwalk.kintera.org/faf/donorReg/donorPledge.asp?ievent=1097721&supid=404648548#sthash.421hhuue.dpuf

I was diagnosed with bladder cancer on November 22, 2011. This walk will mark two years since my cancer metastasized. Currently there is no cure for metastatic bladder cancer. I'm walking to support the research for a cure, and to celebrate the hope and joy of life.

This year, 73,000 people will be diagnosed with bladder cancer. 15,000 people will not survive their bladder cancer journey this year.

Bladder cancer is the 6th most commonly diagnosed cancer in the US. It affects both men and women of all ages and races, although men are 4 times more likely to be diagnosed. Women, however, have higher mortality rates due to delayed diagnosis.

Through innovative programs such as the Bladder Cancer Think Tank - the only scientific symposium dedicated solely to bladder cancer, BCAN is helping to change these odds.

Walk with me or donate and help us beat these odds!

$25 gives 50 people educational materials to navigate their bladder cancer journey
$50 will help produce a webinar about bladder cancer research
$100 helps a Young Investigator attend BCAN's Think Tank

Thank you for stepping up and helping me change the lives of those impacted by bladder cancer. - See more at: http://dcwalk.kintera.org/faf/donorReg/donorPledge.asp?ievent=1097721&supid=404648548#sthash.421hhuue.dpuf
I was diagnosed with bladder cancer on November 22, 2011. This walk will mark two years since my cancer metastasized. Currently there is no cure for metastatic bladder cancer. I'm walking to support the research for a cure, and to celebrate the hope and joy of life.

This year, 73,000 people will be diagnosed with bladder cancer. 15,000 people will not survive their bladder cancer journey this year.

Bladder cancer is the 6th most commonly diagnosed cancer in the US. It affects both men and women of all ages and races, although men are 4 times more likely to be diagnosed. Women, however, have higher mortality rates due to delayed diagnosis.

Through innovative programs such as the Bladder Cancer Think Tank - the only scientific symposium dedicated solely to bladder cancer, BCAN is helping to change these odds.

Walk with me or donate and help us beat these odds!

$25 gives 50 people educational materials to navigate their bladder cancer journey
$50 will help produce a webinar about bladder cancer research
$100 helps a Young Investigator attend BCAN's Think Tank

Thank you for stepping up and helping me change the lives of those impacted by bladder cancer. - See more at: http://dcwalk.kintera.org/faf/donorReg/donorPledge.asp?ievent=1097721&supid=404648548#sthash.421hhuue.dpuf

Wednesday, April 2, 2014

Mets day 720 - Holding Steady

I was supposed to meet today with Dr. Aragon-Ching, my oncologist at GW. We had scheduled the appointment more than a month ago, anticipating that the results of my scan would mean that we'd need to consider additional treatment options. When she learned that the scan detected no new metastases, she emailed me and said that we could cancel our appointment. I was not disappointed.

This past week we've had a rolling celebration of Jennifer's 51st birthday. Over the weekend we gathered with several of her friends for dinner, and also went to a Christopher Cross concert at the Birchmere. His first album was the soundtrack to our courtship in the early 80's, so it was a lovely trip down memory lane. 

I think spring has finally arrived in the DC area, although I can't be sure, since it was snowing two days ago. Yesterday I was walking around the yard, taking inventory of things that needed to be addressed. I fixed two leaking gutters corners, noted several plants that didn't make it through the winter, and turned on the water to the sprinkler system and pool, only to discover a split in a copper riser supply pipe by the pool. I'm going to have to dig around in my workshop for my solder, flux and blowtorch to patch it.

Last week Chelsea learned that she had matched to a medical residency program in Ogden, Utah -- the town where Jennifer grew up, and the closest city to Huntsville, where I grew up. According to Chelsea, the local hospital in Ogden has one of the best family practice residency programs in the country, and she's excited to be training there. They'll move in early June. It's bittersweet news for Jennifer and me, because it means that Chelsea, Josh, and granddaughter Rose soon will be 2000 miles away. We've already made plans to visit them in late June and early July, and Jennifer and I have told each other that we'll be making lots of trips to get our grandparent fix. Meanwhile, we still get to care for her during the days while Chelsea finishes her classes, and we cherish spending time with her -- even when she's crying because she's teething, or is overtired, or just fussy. Enjoy each moment, I tell them, and I'm walking the talk.